“…Closely following the discovery, by Umezawa, Takeuchi and colleagues, of cyclophellitol ( 1 ) and its annotation as a mechanism‐based retaining β‐glucosidase inhibitor, Tatsuta and co‐workers disclosed the first synthesis of cyclophellitol ( 1 ) and cyclophellitol‐aziridine ( 2 ), as well as their configurational analogues 1,6‐ epi ‐cyclophellitol ( 14 , Scheme ) and 1,6‐ epi ‐cyclophellitol‐aziridine 12 (atom numbering as indicated in Figure , compound 1 ). As with most literature syntheses of cyclophellitol, the Tatsuta scheme starts from a chiral building block, here partially protected d ‐idopyranose derivative 4 , which is prepared from l ‐glucose following established procedures . Swern oxidation and Wittig olefination on the primary alcohol is followed by hydrolysis of the methyl acetal.…”